Literature DB >> 12402446

The validity of the Computer Science and Applications activity monitor for use in coronary artery disease patients during level walking.

Ulf Ekelund1, Pia Tingström, Kitty Kamwendo, Monica Krantz, Eva Nylander, Michael Sjöström, Björn Bergdahl.   

Abstract

The principal aim of the present study was to examine the validity of the Computer Science and Applications (CSA) activity monitor during level walking in coronary artery disease (CAD) patients. As a secondary aim, we evaluated the usefulness of two previously published energy expenditure (EE) prediction equations. Thirty-four subjects (29 men and five women), all with diagnosed CAD, volunteered to participate. Oxygen uptake (VO2) was measured by indirect calorimetry during walking on a motorized treadmill at three different speeds (3.2, 4.8 and 6.4 km h-1). Physical activity was measured simultaneously using the CSA activity monitor, secured directly to the skin on the lower back (i.e. lumbar vertebrae 4-5) with an elastic belt. The mean (+/- SD) activity counts were 1208 +/- 429, 3258 +/- 753 and 5351 +/- 876 counts min-1, at the three speeds, respectively (P < 0.001). Activity counts were significantly correlated to speed (r = 0.92; P < 0.001), VO2 (ml kg-1 min-1; r = 0.87; P < 0.001) and EE (kcal min-1; r = 0.85, P < 0.001). A stepwise linear regression analysis showed that activity counts and body weight together explained 75% of the variation in EE. Predicted EE from previously published equations differed significantly when used in this group of CAD patients. In conclusion, the CSA activity monitor is a valid instrument for assessing the intensity of physical activity during treadmill walking in CAD patients. Energy expenditure can be predicted from body weight and activity counts.

Entities:  

Mesh:

Year:  2002        PMID: 12402446     DOI: 10.1046/j.1475-097x.2002.00426.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  6 in total

Review 1.  Accelerometer use with children, older adults, and adults with functional limitations.

Authors:  Scott J Strath; Karin A Pfeiffer; Melicia C Whitt-Glover
Journal:  Med Sci Sports Exerc       Date:  2012-01       Impact factor: 5.411

2.  Plasma adiponectin concentration is associated with the average accelerometer daily steps counts in healthy elderly females.

Authors:  Jaak Jürimäe; Tatjana Kums; Toivo Jürimäe
Journal:  Eur J Appl Physiol       Date:  2010-03-13       Impact factor: 3.078

3.  Subjective and objective levels of physical activity and their association with cardiorespiratory fitness in rheumatoid arthritis patients.

Authors:  Chen-an Yu; Peter C Rouse; Jet J C S Veldhuijzen Van Zanten; Nikos Ntoumanis; George D Kitas; Joan L Duda; George S Metsios
Journal:  Arthritis Res Ther       Date:  2015-03-13       Impact factor: 5.156

4.  Relationships between serum omentin-1 concentration, body composition and physical activity levels in older women.

Authors:  Shuo Li; Jingjing Xue; Ping Hong
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

5.  Randomised controlled trial of a complex intervention by primary care nurses to increase walking in patients aged 60-74 years: protocol of the PACE-Lift (Pedometer Accelerometer Consultation Evaluation - Lift) trial.

Authors:  Tess Harris; Sally Kerry; Christina Victor; Ulf Ekelund; Alison Woodcock; Steve Iliffe; Peter Whincup; Carole Beighton; Michael Ussher; Lee David; Debbie Brewin; Fredrika Adams; Annabelle Rogers; Derek Cook
Journal:  BMC Public Health       Date:  2013-01-04       Impact factor: 3.295

6.  PACE-UP (Pedometer and consultation evaluation--UP)--a pedometer-based walking intervention with and without practice nurse support in primary care patients aged 45-75 years: study protocol for a randomised controlled trial.

Authors:  Tess Harris; Sally M Kerry; Christina R Victor; Sunil M Shah; Steve Iliffe; Michael Ussher; Ulf Ekelund; Julia Fox-Rushby; Peter Whincup; Lee David; Debbie Brewin; Judith Ibison; Stephen DeWilde; Elizabeth Limb; Nana Anokye; Cheryl Furness; Emma Howard; Rebecca Dale; Derek G Cook
Journal:  Trials       Date:  2013-12-05       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.